ScanSource director granted 3,234 shares

Rhea-AI Filing Summary

SCANSOURCE, INC. (SCSC) reported that director Elizabeth Temple Orazem received a grant of 3,234 shares of Common Stock on September 1, 2026, recorded as a grant, award, or other acquisition at $0.00 per share. Following this award, she directly holds 39,127 shares of ScanSource common stock.

The filing indicates this is an acquisition of shares through equity compensation and no Rule 10b5-1 trading plan is reported in connection with this transaction.

Insider Trade Summary

Grant/Award: 3,234 shares

Grant/Award 1 txn

Insider Temple Elizabeth Orazem

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,234	$0.00	$0.00

Holdings After Transaction: Common Stock — 39,127 shares (Direct)

Key Figures

Shares granted: 3,234 shares Price per share: $0.00 per share Shares owned after transaction: 39,127 shares +1 more

4 metrics

Shares granted 3,234 shares Equity grant to director on September 1, 2026

Price per share $0.00 per share Stated value for the 3,234-share grant

Shares owned after transaction 39,127 shares Director’s direct holdings following the grant

Number of acquisition transactions 1 transaction Single reported grant, award, or other acquisition

Key Terms

Grant, award, or other acquisition, Common Stock, Rule 10b5-1

3 terms

Grant, award, or other acquisition financial

"transaction code description indicates a Grant, award, or other acquisition"

Common Stock financial

"security title is listed as Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"document-level Rule 10b5-1 checkbox is not checked"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did SCSC disclose for Elizabeth Temple Orazem?

ScanSource disclosed that director Elizabeth Temple Orazem received a grant of 3,234 shares of common stock on September 1, 2026, classified as a grant, award, or other acquisition at $0.00 per share as part of equity compensation.

How many SCSC shares does Elizabeth Temple Orazem own after this grant?

After the September 1, 2026 grant, Elizabeth Temple Orazem directly holds 39,127 shares of ScanSource common stock, according to the Form 4 disclosure.

Was the SCSC insider transaction made under a Rule 10b5-1 trading plan?

No. The Form 4 for ScanSource indicates the document-level Rule 10b5-1 checkbox is not checked, so no Rule 10b5-1 trading plan is reported for this transaction.

What type of transaction was reported for SCSC common stock?

The transaction is reported as a grant, award, or other acquisition of common stock, coded as an acquisition (code A) for 3,234 shares at a stated price of $0.00 per share.

Does the SCSC Form 4 report any stock sales or derivative exercises?

No. The Form 4 reports only one acquisition transaction of 3,234 common shares and shows no sales, gifts, or derivative exercises in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 07:02 PM Accepted by SEC EDGAR 09/03/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Temple Elizabeth Orazem

(Last) (First) (Middle)

6 LOGUE COURT

(Street)

GREENVILLE SOUTH CAROLINA 29615

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCANSOURCE, INC. [ SCSC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		3,234	A	$0.00	39,127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	J. Creighton Lynes, attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)